Yeah, I am very surprised how little interest this has. The upside of this is though that once the market see's the ANN it wants there will be a swift re-rate into the mid to high 70's IMO.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
Week 48 Wrap: ASX flirts with 8,500pts; APRA declines mortgage loan easing; Trump's Bessent tied to Dem donor
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
